Showing results (1761-1770 of 2,695) with videos related to

Sort By:
Pageof 270
The American Journal of Tropical Medicine and Hygiene|March 8, 2021
The Effect of Drug Pricing on Outpatient Payments and Treatment for Three Soil-Transmitted Helminth Infections in the United States, 2010-2017Heesoo Joo, Junsoo Lee, Brian A Maskery, et al.
The Annals of Thoracic Surgery|July 2, 2011
Undersized tricuspid annuloplasty rings optimally treat functional tricuspid regurgitationMehrdad Ghoreishi, Jamie M Brown, Craig E Stauffer, et al.
Journal of Atmospheric Chemistry|December 23, 2015
Ozone profiles in the Baltimore-Washington region (2006-2011): satellite comparisons and DISCOVER-AQ observationsAnne M Thompson, Ryan M Stauffer, Sonya K Miller, et al.
Open Heart|February 3, 2016
Heart rate never lies: interventional cardiologist and Braude's quote revisedStéphane Cook, Jean-Christophe Stauffer, Jean-Jacques Goy, et al.
Schweizerische Medizinische Wochenschrift|January 11, 1994
[How long should cyclosporin be administered following bone marrow transplantation?]A Gratwohl, A Tichelli, G Stauffer, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 1, 1995
Histomorphometric analysis of iliac crest bone biopsies in placebo-treated versus fluoride-treated subjectsM W Lundy, M Stauffer, J E Wergedal, et al.
Methodsx|July 10, 2018
Optimization of phenol-chloroform RNA extractionLee S Toni, Anastacia M Garcia, Danielle A Jeffrey, et al.
American Journal of Human Genetics|July 1, 1992
Linkage of a variant or attenuated form of adenomatous polyposis coli to the adenomatous polyposis coli (APC) locusL Spirio, B Otterud, D Stauffer, et al.
Ugeskrift for Laeger|October 13, 2006
[New molecular markers within the chronic myeloproliferative disorders. I: the PRV-1 gene]Thomas Stauffer Larsen, Niels Pallisgaard, Jacob Haaber Christensen, et al.
Ugeskrift for Laeger|October 13, 2006
[New molecular markers within the chronic myeloproliferative disorders. II: the JAK2 mutation]Thomas Stauffer Larsen, Niels Pallisgaard, Jacob Haaber Christensen, et al.
Pageof 270